Table 3.
Treatment Consideration | Nature | Findings |
Dietary adjustments | Animal protein, saturated fats[90] | Bacteroides, Firmicutes (including Clostridia), and Prevotella favored by different dietary regimens[37,90] |
High carbohydrate diets[90] | ||
Low fat high fiber diet[90] | ||
Probiotic preparations | Bifidobacterium bifidum[253] | Expands Tregs in cell culture[278] |
Lactobacillus strains[254,263,266] | Prevents diabetes in NOD mice[263] | |
Lactobacillus rhamnosus[276] | Improves liver tests in rat model[266] | |
Anaerostipes caccae[277] | Increases tight junction proteins[276] | |
Consumes lactate and produces butyrate[277] | ||
Vitamin A and retinoic acid | Retinoic acid supplement[255] | Restores Lactobacilli in lupus model[255] |
Dietary vitamin A[256] | Regulates cytokines in lupus model[256] | |
Induces IL-10-producing Tregs[279] | ||
Antibiotics | Tetracycline, minocycline[257] | Reduces activity in RA[257] |
Vancomycin, metronidazole[269] | Improves tests and pruritus in PSC[269] | |
Re-colonization | Bacteroides fragilis[107] | Induces Tregs in colitis model[107,109,110] |
Fecal transplantation | Clostridia species[109,110] | |
Intestinal barrier protectors | Gelatin tannate[258-260] | Enhances mucus barrier[258,259] |
Reduces activity in murine colitis[259] | ||
Alters composition of microbiota[259] | ||
Limits inflammatory effects of LPS[260] | ||
Inhibits IL-8 and TNF-α in LPS cells[260] | ||
TLR inhibitors | Oligodeoxynucleotides blocking TLR7 signaling[261] | Improves tests and reduces activity in murine model of lupus nephritis[261] |
Improves autoimmune lung injury[261] | ||
Molecular interventions | Polysaccharide A[105,262] | Induces IL-10 producing Tregs[105,262] |
Protects against EAE in mice[105] | ||
Short chain fatty acids | Acetate, propionate, butyrate[200] | Modulates gut signaling pathways[200] |
Inhibits histone deacetylases[200,264] | ||
Regulates gene expression[200] | ||
Enhances gut integrity[200] |
Superscripted numbers in brackets are references. EAE: Experimental autoimmune encephalitis; IL: Interleukin; LPS: Lipopolysaccharide; NOD: Non-obese diabetes; PSC: Primary sclerosing cholangitis; RA: Rheumatoid arthritis; TLR: Toll-like receptor; TNF-α: Tumor necrosis factor-alpha; Tregs: Regulatory T cells.